NeoPharm CO., LTD. Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 6, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	306,725	180,766	202,163	150,156	193,952	223,279
Market Cap Growth	74.39%	-10.58%	34.63%	-22.58%	-13.13%	-40.95%
Enterprise Value	174,024	66,098	78,166	45,545	97,728	138,586
Last Close Price	19610.00	11384.69	11811.25	8517.25	10615.43	11883.80
PE Ratio	11.03	7.84	8.71	8.82	10.95	12.32
Forward PE	9.58	8.05	8.05	8.05	10.43	12.07
PS Ratio	2.36	1.52	2.08	1.77	2.21	2.74
PB Ratio	1.63	1.02	1.26	1.06	1.49	1.90
P/TBV Ratio	1.64	1.03	1.28	1.07	1.51	1.94
P/FCF Ratio	10.69	11.42	59.27	8.48	9.08	13.30
P/OCF Ratio	10.25	9.70	8.69	8.27	8.95	13.08
PEG Ratio	-	5.64	5.64	5.64	5.64	1.25
EV/Sales Ratio	1.34	0.56	0.81	0.54	1.11	1.70
EV/EBITDA Ratio	5.55	2.38	2.90	1.98	4.08	5.92
EV/EBIT Ratio	6.16	2.68	3.09	2.12	4.36	6.33
EV/FCF Ratio	6.07	4.18	22.92	2.57	4.58	8.26
Debt / Equity Ratio	0.01	0.00	0.01	0.00	0.00	0.04
Debt / EBITDA Ratio	0.04	0.02	0.04	0.02	0.02	0.18
Debt / FCF Ratio	0.05	0.04	0.31	0.02	0.03	0.26
Asset Turnover	0.66	0.64	0.58	0.57	0.64	0.64
Inventory Turnover	3.01	3.93	3.35	3.19	3.18	3.30
Quick Ratio	8.32	9.21	7.22	9.22	8.74	7.06
Current Ratio	9.36	10.12	7.94	9.99	9.39	7.63
Return on Equity (ROE)	15.49%	13.69%	15.36%	12.50%	14.28%	16.23%
Return on Assets (ROA)	9.02%	8.33%	9.50%	8.97%	10.14%	10.71%
Return on Invested Capital (ROIC)	43.37%	37.61%	51.12%	56.96%	64.53%	68.30%
Return on Capital Employed (ROCE)	14.90%	13.90%	15.80%	15.10%	17.20%	18.50%
Earnings Yield	9.06%	12.76%	11.48%	11.34%	9.13%	8.12%
FCF Yield	9.35%	8.76%	1.69%	11.79%	11.01%	7.52%
Dividend Yield	3.82%	5.27%	3.17%	4.11%	3.30%	2.73%
Payout Ratio	33.76%	25.43%	23.58%	32.15%	28.70%	32.35%
Buyback Yield / Dilution	-	-	-	-	0.95%	-4.38%
Total Shareholder Return	3.82%	5.27%	3.17%	4.11%	4.24%	-1.64%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.